April 3, 2009 Conflicts for FDA committee set to weigh risks of Seroquel_Philadelphia InquirerAdvisory panel recommendations for expanded marketing approval are usually followed by the FDA. Philadelphia Inquirer journalist, Miriam Read More Conflicts for FDA committee set to weigh risks of Seroquel_Philadelphia Inquirer